cURL Error: Failed to connect to 217.15.170.3 port 80 after 3118 ms: Couldn't connect to server
Regeneron Pharmaceuticals Inc. REGN Leads Biotech Industry with Innovative Drug Developments
January 18, 2026
Regeneron Pharmaceuticals Inc. REGN Receives Positive Opinion from European Medicines Agency
October 31, 2025
Regeneron Pharmaceuticals Inc. Continues to Impress Investors with Strong Performance
September 5, 2025
Regeneron Pharmaceuticals: Revolutionizing Healthcare with Innovative Drug Approvals
July 5, 2025
Regeneron Pharmaceuticals Inc. Continues to Impress Investors as UBS Lowers Price Target
June 27, 2025
REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 33.76% Profit Margin
June 5, 2025
Regeneron Pharmaceuticals Inc. Faces Class Action Lawsuit
February 2, 2025
Regeneron Pharmaceuticals REGN Faces Securities Class Action After Losing 9 Billion Value Following Q3 2024 Earnings Report
January 22, 2025
Regeneron Pharmaceuticals Faces Securities Class Action After 9 Billion Value Loss
January 23, 2025
Regeneron Pharmaceuticals Faces Shareholder Class Action Lawsuit
January 12, 2025
Analyst Cuts Regeneron Pharmaceuticals REGN Price Target After Sales Concerns and Investor Lawsuit Hagens Berman
February 13, 2025
Investor opinions & comments
To leave a comment, you need to Login or Register.
There are no comments yet. Be the first to leave one!